Abstract
The jellyfish Nemopilema nomurai was hydrolyzed with papain and a novel dipeptide purified via ultrafiltration, gel filtration chromatography with Sephadex LH-20, and reverse phase chromatography using C18 and C12 columns. The IR, 1H NMR, 13C NMR, and MS spectrometer analyses showed that the dipeptide comprised tyrosine-isoleucine (Tyr-Ile). The IC50 and Ki values were 6.56 ± 1.12 and 3.10 ± 0.28 μM, respectively, indicating competitive inhibition of angiotensin-I-converting enzyme (ACE). As a novel ACE-inhibitory active peptide, Tyr-Ile may have potential for use in antihypertensive therapy. © The Korean Society of Fisheries and Aquatic Science.
Author supplied keywords
Cite
CITATION STYLE
Kim, Y. K., Lim, C. W., Yeun, S. mi, Lee, M. H., Moon, H. S., Cho, H. A., … Lee, D. S. (2012). Dipeptide (Tyr-Ile) acting as an inhibitor of angiotensin-I-converting enzyme (ACE) from the hydrolysate of jellyfish nemopilema nomurai. Fisheries and Aquatic Sciences, 14(4), 283–288. https://doi.org/10.5657/FAS.2011.0283
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.